RECENT NEWS

Endotoxin testing is a vital assay for all injectable or implantable products. PYROSTAR, now available from Alpha Laboratories, enables in-house endotoxin testing, providing full control over one of the most important aspects of quality control.

The British In Vitro Diagnostics Association (BIVDA) has welcomed publication of ‘Diagnostics: Recovery and Renewal’, a major review of diagnostic services by NHS England.

Xyall, an innovator in molecular pathology, has entered a strategic partnership with Motic, a world leader in microscopy and digital pathology systems, to develop an automated tumour tissue dissection solution for molecular pathology laboratories.

Mast has been awarded the Public Health England (PHE) tender for the exclusive supply of antibiotic susceptibility (AST) and AMR discs. Mast is delighted with this decision and looks forward to strengthening its existing relationship with PHE.

Publication of the October issue of Pathology in Practice is imminent, offering its usual mixture of news, professional, commercial and scientific features.

PCR Biosystems has expanded its range of molecular biology kits by introducing the NGSBIO Library Quant Kit for Illumina, which contains everything necessary for quantification of DNA libraries prior to NGS with Illumina platforms.

The British In Vitro Diagnostics Association (BIVDA) has commented on a recent NHS Confederation report, which focuses on the policy levers needed to put the NHS back onto a secure footing in the months ahead.

Diaceutics has announced three new partnerships on its DXRX platform, as it continues on its mission to get every patient the treatment they deserve.

FUJIFILM Irvine Scientific has become the exclusive, worldwide distributor of Cellnest, a recombinant peptide attachment substrate that offers optimal adhesion and proliferation of stem cells in chemically defined, animal component-free conditions.

Easyfairs has announced that its Lab Innovations 2020 event, which was due to take place on 4–5 November at the NEC, Birmingham, is now postponed until 3–4 November 2021.

In the September 2020 digital issue, Pathology in Practice concatenates seven articles written by Dr Stephen MacDonald on various aspects of measurement uncertainty evaluation, and their importance commercially and professionally.

The NHS recently announced a £50 million fund to accelerate AI-based technologies for improving healthcare. Among the 42 funded recipients, Ibex Medical Analytics was the sole company chosen that offers AI tools for pathology.

The British In Vitro Diagnostics Association (BIVDA) has called on the Chancellor, Rishi Sunak, to put support for the UK IVD industry at the forefront of the forthcoming Comprehensive Spending Review.

The British In Vitro Diagnostics Association (BIVDA) is running an online Expo as a service to its members, which will take the form of a virtual tradeshow running on 10–12 November.

Thermo Fisher Scientific has announced collaborations of the Thermo Fisher Precision Medicine Science Center with AstraZeneca and the University of Nebraska Medical Center in development of innovative solutions in clinical biomarker discovery.

Diaceutics has announced the establishment of a dedicated Advisory Panel of experts to support and inform the development and rollout of its DXRX platform – the world’s first diagnostic network for precision medicine.

Bio-Rad Laboratories has announced the launch of StarBright Violet 515 (SBV515) dye, the first of a new range of fluorescent nanoparticles, for use in flow cytometry and compatible with most flow cytometers and experimental protocols.

Stago has updated its free, interactive Haemoscore app, designed to facilitate faster and more accurate decision-making in thrombotic and bleeding problems. The original app has already been downloaded by more than 12,000 users worldwide.

CellDrop from DeNovix has won many fans among life scientists since its launch in 2019. At the recent Scientists' Choice Awards, it was voted Life Science Best New Product of the Year.

The British In Vitro Diagnostics Association (BIVDA) has joined over 30 top pharmaceutical, IVD and health technology bodies to sign an open letter to the Prime Minister urging government to provide financial support for medical research charities.